Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28576 - 28600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	PAMR1	25891	downregulated	Cytarabine results in decreased expression of PAMR1 mRNA	11p13	A21886
Cytarabine	Approved Investigational	PARD6A	50855	downregulated	Cytarabine results in decreased expression of PARD6A mRNA	16q22.1	A20985
Cytarabine	Approved Investigational	PARM1	25849	downregulated	Cytarabine results in decreased expression of PARM1 mRNA	4q13.3	A21886
Cytarabine	Approved Investigational	PAX6	5080	upregulated	Cytarabine results in increased expression of PAX6 mRNA	11p13	A21886
Cytarabine	Approved Investigational	PCDH20	64881	downregulated	Cytarabine results in decreased expression of PCDH20 mRNA	13q21.2	A21886
Cytarabine	Approved Investigational	PCDH7	5099	downregulated	Cytarabine results in decreased expression of PCDH7 mRNA	4p15.1	A21886
Cytarabine	Approved Investigational	PCED1B	91523	downregulated	Cytarabine results in decreased expression of PCED1B mRNA	12q13.11	A21886
Cytarabine	Approved Investigational	PCSK5	5125	downregulated	Cytarabine results in decreased expression of PCSK5 mRNA	9q21.13	A21886
Cytarabine	Approved Investigational	PDE1A	5136	upregulated	Cytarabine results in increased expression of PDE1A mRNA	2q32.1	A21886
Cytarabine	Approved Investigational	PDE1B	5153	upregulated	Cytarabine results in increased expression of PDE1B mRNA	12q13.2	A21886
Cytarabine	Approved Investigational	PDE4B	5142	upregulated	Cytarabine results in increased expression of PDE4B mRNA	1p31.3	A21886
Cytarabine	Approved Investigational	PDE6D	5147	downregulated	Cytarabine results in decreased expression of PDE6D mRNA	2q37.1	A20985
Cytarabine	Approved Investigational	PDGFRB	5159	downregulated	Cytarabine results in decreased expression of PDGFRB mRNA	5q32	A21886
Cytarabine	Approved Investigational	PDLIM3	27295	upregulated	Cytarabine results in increased expression of PDLIM3 mRNA	4q35.1	A21886
Cytarabine	Approved Investigational	PDPN	10630	downregulated	Cytarabine results in decreased expression of PDPN mRNA	1p36.21	A21886
Cytarabine	Approved Investigational	PELI1	57162	upregulated	Cytarabine results in increased expression of PELI1 mRNA	2p14	A21886
Cytarabine	Approved Investigational	PFKP	5214	downregulated	Cytarabine results in decreased expression of PFKP mRNA	10p15.2	A21886
Cytarabine	Approved Investigational	PGM5	5239	downregulated	Cytarabine results in decreased expression of PGM5 mRNA	9q21.11	A21886
Cytarabine	Approved Investigational	PHACTR2	9749	downregulated	Cytarabine results in decreased expression of PHACTR2 mRNA	6q24.2	A21886
Cytarabine	Approved Investigational	PHYHIPL	84457	upregulated	Cytarabine results in increased expression of PHYHIPL mRNA	10q21.1	A21886
Cytarabine	Approved Investigational	PIGH	5283	downregulated	Cytarabine results in decreased expression of PIGH mRNA	14q24.1	A21886
Cytarabine	Approved Investigational	PITX1	5307	downregulated	Cytarabine results in decreased expression of PITX1 mRNA	5q31.1	A21886
Cytarabine	Approved Investigational	PITX2	5308	downregulated	Cytarabine results in decreased expression of PITX2 mRNA	4q25	A21886
Cytarabine	Approved Investigational	PKIA	5569	downregulated	Cytarabine results in decreased expression of PKIA mRNA	8q21.13	A21886
Cytarabine	Approved Investigational	PKP2	5318	downregulated	Cytarabine results in decreased expression of PKP2 mRNA	12p11.21	A21886

Displaying entries 28576 - 28600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability